Le Lézard
Classified in: Health, Business
Subject: AWD

Realty Trust Group Recognized by Modern Healthcare as One of the Best Places to Work in Healthcare


KNOXVILLE, Tenn., May 27, 2021 /PRNewswire/ -- Realty Trust Group has been selected by Modern Healthcare as one of the 2021 Best Places to Work in Healthcare.

"RTG is known for our people," says Greg Gheen, President of Realty Trust Group. "As our company has grown to nearly 100 employees across six regional offices, our culture and workplace environment have been key to our continued success.  We are proud to receive this honor and more dedicated than ever to maintaining an energetic, innovative, and supportive work environment to retain top talent, empower our team to thrive, and deliver results for our clients."

"One year into the pandemic, we've seen the industry transform to meet the needs of its patients and employees," said Aurora Aguilar, Modern Healthcare's editor. "Time and time again, the most resilient and successful organizations show that empathy towards their staff, clear vision and compassion towards the patient buoys teams and sets them up for success. We congratulate the Best Places to Work in Healthcare for eliciting loyalty from their workforce and communities during harrowing times."

This award program identifies and recognizes outstanding employers in the healthcare industry nationwide. Modern Healthcare partners with the Best Companies Group on the assessment process, which includes an extensive employee survey.

The complete list of this year's winners, in alphabetical order, is available at ModernHealthcare.com/bestplaceslist. Modern Healthcare will publish a special supplement featuring a ranked list of all the winners along with its September 20 issue.

About Realty Trust Group
Realty Trust Group, LLC ("RTG") is a real estate advisory and services firm offering a full spectrum of real estate services including advisory, development, transactions, operations and compliance.

Since 1998, RTG has helped hospitals, physician groups, and property owners navigate the rapidly changing industry with growth strategies that gain market leadership as well as enhance patient and physician experiences for better delivery of care. Our philosophy is to provide innovative solutions to the complex and challenging issues found in today's healthcare real estate market. These solutions include strategic campus and facility planning, portfolio optimization, portfolio monetization, project development, leasing, acquisition and disposition services, portfolio management, regulatory compliance and many other ideas and services. For more information about RTG and our innovative healthcare real estate services, visit www.realtytrustgroup.comFacebookLinkedIn, or call 865-521-0630.

Contact: Angie Surface
Realty Trust Group
Phone: 865-684-2891
Email: [email protected] 
Website: www.realtytrustgroup.com

 

SOURCE Realty Trust Group LLC


These press releases may also interest you

at 08:25
NOVA LEAP HEALTH CORP. ("Nova Leap" or "the Company"), a growing home health care organization, is pleased to announce that it has executed a definitive agreement (the "Agreement"), dated April 25, 2024, to acquire a home care services company ("the...

at 08:20
Coya Therapeutics, Inc. ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, announces that Dr. Stanley Appel, M.D., Chairman of Coya's Scientific Advisory...

at 08:19
Nitto Denko Avecia Inc. and Nitto Denko Avecia Pharma Services (Nitto Avecia), a global leader in contract development and manufacturing of oligonucleotides for the therapeutic market announced today that Tammy Cooper will be appointed President of...

at 08:05
Gilead Sciences, Inc. today announced the U.S. Food and Drug Administration (FDA) approved an updated label with additional data reinforcing the safety and efficacy profile of Biktarvy® (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide...

at 08:05
Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (MDNAF: OTCQB), a clinical-stage immunotherapy company focused on the development of engineered cytokines, today announced a CA$20 million investment by RA Capital Management, a multi-stage...

at 08:02
Sobi® today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued a positive opinion recommending approval of efanesoctocog alfa, for the treatment and prevention of bleeds and perioperative...



News published on and distributed by: